Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
Clinical trial NCT05485818 · COMPLETED
Trial details
- NCT number
- NCT05485818
- Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2021-09-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.